Transaction · 0001214659-26-010645

Finn Patrick John

Finn Patrick John, PRES, reported an open-market or private sale at Twist Bioscience Corp involving 12917.000000 shares for an estimated $1548205.79. Reported holdings after the transaction were 222974.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SPRES
TWSTTwist Bioscience Corp
Estimated value-$1.54MShares × reported price
Shares traded12.9k$119.86 per share
Holdings after222kDirect
% of reported position traded5.48%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 235,891 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

TWST price since this filing

Daily closing prices, with the filing date and available return windows
TWST · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -31.1%1w ago -9.6%1d ago -8.7%
Returns since7d +12.4%30d +22.6%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001214659-26-010645
Common Stock
Transaction date
Aug 18, 2026
Filed Aug 20, 2026, 08:05 PM · 2d delay
Shares
12,917 sh
$119.86 per share
Estimated value
-$1.54M
Computed from shares × price
Holdings after
222,974 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Sale Repeat Seller 10b5-1 Detected
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President and COO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The transactions reported on this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 18, 2026.

  2. F2

    Represents the weighted average sales price per share. The shares sold at prices ranging from $115.35 to $116.33 per share. Full information regarding the number of shares sold at each price shall be…

  3. F3

    Represents the weighted average sales price per share. The shares sold at prices ranging from $116.37 to $117.36 per share. Full information regarding the number of shares sold at each price shall be…

  4. F4

    Represents the weighted average sales price per share. The shares sold at prices ranging from $117.37to $118.19 per share. Full information regarding the number of shares sold at each price shall be p…

  5. F5

    Represents the weighted average sales price per share. The shares sold at prices ranging from $118.505 to $119.45 per share. Full information regarding the number of shares sold at each price shall be…

  6. F6

    Represents the weighted average sales price per share. The shares sold at prices ranging from $119.515 to $120.2 per share. Full information regarding the number of shares sold at each price shall be…

  7. F7

    Represents the weighted average sales price per share. The shares sold at prices ranging from $120.585 to $121.53 per share. Full information regarding the number of shares sold at each price shall be…

  8. F8

    Represents the weighted average sales price per share. The shares sold at prices ranging from $122.00 to $122.815 per share. Full information regarding the number of shares sold at each price shall be…

  9. F9

    The option was 100% exercisable on December 19, 2022.

Original filing · 0001214659-26-010645
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TWST